EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

Antimicrobial Activity of D-Form Synthetic Peptides Against Metronidazole-Resistant and Susceptible Trichomonas vaginalis: A Comparative Transcriptomic Analysis

Özben Özden iD, Tuba Polat iD, Tanıl Kocagöz, Özgür Kurt iD

International Journal of Molecular Sciences · 23.04.2026 · 27 (9) · 3747

DOI: 10.3390/ijms27093747 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 23.04.2026. Verfasst von Özben Özden und 3 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School of Health Sciences, Department of Medical Biotechnology, Acibadem University, Istanbul 34752, Türkiye. Hauptthemen laut MEDLINE: Trichomonas vaginalis, Metronidazole, Antimicrobial Peptides, Drug Resistance. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Trichomonas vaginalis is the causative agent of trichomoniasis, the most common non-viral sexually transmitted infection worldwide. In these cases, 5-Nitroimidazoles, particularly metronidazole (MTZ), remain the primary treatment option; however, resistance to MTZ has been increasingly reported. This study aimed to evaluate the in vitro activity of D-form synthetic antimicrobial peptides and investigate transcriptional differences associated with MTZ resistance and peptide treatment in T. vaginalis. D-form synthetic peptides (D-TN1, D-TN3, and D-TN6) developed in the R&D Laboratory of Acibadem University were tested against metronidazole-susceptible (T. vaginalis ATCC 30236) and metronidazole-resistant (T. vaginalis ATCC 50143) strains by minimum lethal concentration (MLC) assays. D-TN1 exhibited an MLC of 16 µg/mL in both strains, whereas D-TN3 and D-TN6 exhibited MLC values of 32 µg/mL and 16–32 µg/mL, respectively. Comparative transcriptomic analysis was conducted to investigate transcriptional differences. Differential gene expression analysis identified 3395 genes between the resistant and susceptible isolates and 3060 genes in the D-TN1-treated resistant isolate (FDR < 0.05, |log2FC| ≥ 1). D-TN1 treatment in the resistant isolate was associated with downregulation of ribosomal and metabolic pathways. If confirmed with further in vivo studies, this new antimicrobial peptide may become a new therapeutic alternative in the treatment of trichomoniasis in the future.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Trichomonas vaginalisMetronidazoleAntimicrobial PeptidesDrug ResistanceTranscriptomeGene Expression ProfilingMicrobial Sensitivity TestsHumans

Stichwörter der Autor:innen

Trichomonas vaginalisantimicrobial peptidesdrug resistancemetronidazoletranscriptome

Substanzen

MetronidazoleAntimicrobial Peptides

Autor:innen und Institutionen

  • Graduate School of Health Sciences, Department of Medical Biotechnology, Acibadem University, Istanbul 34752, Türkiye.
  • Department of Medical Microbiology, Acibadem University School of Medicine, Istanbul 34752, Türkiye.

ORCID-Profile: Özben Özden, Tuba Polat, Özgür Kurt

Zitieren

APA

Özden, Ö., Polat, T., Kocagöz, T., & Kurt, Ö. (2026). Antimicrobial Activity of D-Form Synthetic Peptides Against Metronidazole-Resistant and Susceptible Trichomonas vaginalis: A Comparative Transcriptomic Analysis. International Journal of Molecular Sciences, 27(9), 3747. https://doi.org/10.3390/ijms27093747

Vancouver

Özden Ö, Polat T, Kocagöz T, Kurt Ö. Antimicrobial Activity of D-Form Synthetic Peptides Against Metronidazole-Resistant and Susceptible Trichomonas vaginalis: A Comparative Transcriptomic Analysis. International Journal of Molecular Sciences. 2026;27(9):3747. doi:10.3390/ijms27093747

BibTeX
@article{zden2026,
  author = {Özden, Özben and Polat, Tuba and Kocagöz, Tanıl and Kurt, Özgür},
  title = {Antimicrobial Activity of D-Form Synthetic Peptides Against Metronidazole-Resistant and Susceptible Trichomonas vaginalis: A Comparative Transcriptomic Analysis},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {9},
  pages = {3747},
  doi = {10.3390/ijms27093747}
}
Kostenlos starten →